| Dr Fayez Shamoon, MD | |
|
35-37 Progress St, Edison, NJ 08820 | |
| (908) 754-9292 | |
| (908) 754-3358 |
| Full Name | Dr Fayez Shamoon |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 35-37 Progress St, Edison, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528053477 | NPI | - | NPPES |
| 6884504 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA05551600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital And Medical Center | Paterson, NJ | Hospital |
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Saint Michael's Medical Center | Newark, NJ | Hospital |
| Trinitas Regional Medical Center | Elizabeth, NJ | Hospital |
| Entity Name | St Josephs Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497791297 PECOS PAC ID: 9739171984 Enrollment ID: O20040330001612 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Entity Name | Comprehensive Cardiovascular Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467485623 PECOS PAC ID: 3476656745 Enrollment ID: O20070307000589 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Entity Name | St Michaels Cardiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457481954 PECOS PAC ID: 9830224153 Enrollment ID: O20100311000818 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Entity Name | Medical Associates Of Englewood Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952681918 PECOS PAC ID: 1355512252 Enrollment ID: O20110927000020 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Entity Name | Trinitas Physicians Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205189941 PECOS PAC ID: 6709002850 Enrollment ID: O20140725000027 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Entity Name | St Josephs Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205425519 PECOS PAC ID: 8628470325 Enrollment ID: O20210716000520 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Fayez Shamoon, MD 35-37 Progress St, Edison, NJ 08820 Ph: (908) 754-9292 | Dr Fayez Shamoon, MD 35-37 Progress St, Edison, NJ 08820 Ph: (908) 754-9292 |
News Archive
Light enhances brain activity during a cognitive task even in some people who are totally blind, according to a study conducted by researchers at the University of Montreal and Boston's Brigham and Women's Hospital.
Arena Pharmaceuticals, Inc. today announced that Eisai Inc. will market lorcaserin for obesity and weight management in the United States following U.S. Food and Drug Administration (FDA) approval under the terms of a marketing and supply agreement between Arena Pharmaceuticals GmbH, a wholly owned subsidiary of Arena Pharmaceuticals, Inc., and Eisai. Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
The goal in treating patients with gout is to reduce acute attacks by lowering serum urate levels, which are usually high in this disease.
A number of groups that represent hospitals, physicians, dentists and other health care providers in California on Monday filed a lawsuit in Los Angeles Superior Court to prevent a scheduled 10% reduction in reimbursements under Medi-Cal, the state Medicaid program, the Wall Street Journal reports.
A new study on a mouse model of asthma shows that nerve cells producing dopamine, a neurotransmitter, signal T cells in the body to promote inflammation due to allergic reactions in the lungs during childhood but not in adult mice.
› Verified 6 days ago
Dr. Vasilios Velmahos, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 113 James St, Edison, NJ 08820 Phone: 732-906-1900 Fax: 732-906-6666 | |
Dr. Pankaj Gupta, MD, MBA Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 31 Southfield Rd, Edison, NJ 08820 Phone: 860-989-8829 | |
Dr. Howard S. Cohen, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98 James St, Suite 313, Edison, NJ 08820 Phone: 732-635-0916 Fax: 732-494-4907 | |
Dr. Malvin S Keller, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 225 May St, Suite F, Edison, NJ 08837 Phone: 732-738-8855 Fax: 732-738-4141 | |
Charumathi Rathnakumar, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Progress St, Suite A-4, Edison, NJ 08820 Phone: 732-514-9624 Fax: 732-377-3767 | |
Anil Kumar Singh, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1740 Oak Tree Rd Ste B, Edison, NJ 08820 Phone: 732-494-5000 Fax: 732-494-6698 | |
Dr. Aron A Barsky, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4 Ethel Rd, Suite 405b, Edison, NJ 08817 Phone: 732-287-0255 Fax: 732-287-0355 |